BRIEF-Merck KGAA and Pfizer receive FDA breakthrough status for Avelumab
November 18, 2015 at 07:08 AM EST
* Merck KGAA and Pfizer receive FDA breakthrough therapy designation for Avelumab in metastatic merkel cell carcinoma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.